What's the Land of Tomorrow of #IO in #NSCLC?
At #ESMOImmune2024 I had the honor to discuss the data on
🔴 PDC*lung01 vaccine + Pembro in 1L PD-L1 high
🔴 Inupadenant +carbo/pem after IO failure
🔴 Effectiveness & immunophenotype in orphan genomic alterations
@oncoalert.bsky.social #lcsm

Exciting data at #ESMOImmumo2024 showed by George Coukos on adoptive immune cell therapies:
🔵 Nb of reactive antitumor TILs that are injected correlate with response
🔵 How to improve #TIL treatments in pts with #melanoma
@oncoalert.bsky.social

How to counteract the immunosuppressive action of #adenosine in #TNBC?
@laubdh.bsky.social explains her journey from bench to bedside with the SYNERGY and NeoCheckRay trials & the intense ongoing TR to understand who're the pts who benefit from anti-CD73 🔬👏💪
@oncoalert.bsky.social #ESMOImmuno2024

Impressive talk by Barbara Pistilli on #ADCs at the 18th Belgian Symposium on the
Integration of Molecular Biology Advances into Oncology Clinical Practice by #BSMO & #JulesBordet 🚨
🔴How ADCs are made?
🔴What mechanisms of resistance?
🔴How to improve efficacy?
@oncoalert.bsky.social